NCT00165685View on ClinicalTrials.gov

A Comparative Study of KES524 in Patients With Obesity Disease

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Obesity
Interventions
DRUG

Sibutramine Hydrochloride Monohydrate

Trial Locations (20)

260-0856

Chiba

277-0004

Kashiwa

285-0841

Sakura

960-1247

Fukushima

963-8022

Kōriyama

371-0034

Maebashi

313-0014

Hitachiota

311-4153

Mito

311-0113

Naka

300-0053

Tsuchiura

305-0005

Tsukuba

980-0011

Sendai

980-0872

Sendai

101-0062

Chiyoda-ku

102-0071

Chiyoda-ku

103-0026

Chuo-ku

193-0944

Hachiōji

173-0032

Itabashi-ku

105-0003

Minato-ku

150-0012

Shibuya-ku

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT00165685 - A Comparative Study of KES524 in Patients With Obesity Disease | Biotech Hunter | Biotech Hunter